Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

NCT00535314 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: RTA 402 Dose1
DRUG: RTA 402 Dose2

Sponsor

Biogen